Doença de Hodgkin em doente VIH positivo: dois casos
Palavras-chave:
Febre, doença de Hodgkin, infecção VIHResumo
Os autores apresentam dois casos de febre prolongada em
doente com infecção VIH. O seu estudo conduziu ao diagnóstico
de Doença de Hodgkin.
Downloads
Referências
Gérard L, Galicier L, Boulanger E et al. Improved survival in HIV-related Hodgkin lymphoma since the introduction of highly active antiretroviral therapy, AIDS 2003:17: 81-87.
Tirelli U, Errante D, Dolcetti R et al. Hodgkin disease and human imunodeficiency virus infection: clinicopathologic and virulogic features of 114 patients from Italian cooperative group on AIDS and tumors, Journal of clinical oncology 1995;13: 1758-1767.
Serraino D, Boschini A, Carrieri P et al. Cancer risk among men with, or at risk of, HIV infection in southern Europe, AIDS 2000; 14 (5): 553-559.
Powles T, Bower M. HIV-associated Hodgkin disease, Int J STD AIDS 2000; 11(8); 492-494.
Spina M, Vaccher E, Nasti G, Tirelli U. Human immunodeficiency virus-associated Hodgkin`s disease, Semin Oncol 2000; 27 (4):480-488.
Grulich A, Wan X, Law M, Coates M, Kaldor M. Risk of cancer in people with AIDS, AIDS 1999;13:839-843.
Levine AM. Clinical aspects of AIDS- Related Lymphoma and Hodgkin Disease, 6th International Conference of Malignancies in AIDS & other Immunodeficiencies 2001.
Ribera JM, Navarro JT, Oriol A et al. Prognostic impact of active antiretroviral therapy in HIV-related Hodgkin´s disease, AIDS 2002;16 (14) 1973-1975.
Kaplan LD. Clinical Presentation and Management of HIV- Associated Lymphoma, HIV inSite Knowledge Base Chapter Published November, 1998.
Levine A, Li P, Cheung T et al. Chemotherapy consisting of Doxurobicin, Bleomicin, Vimblastin, and Dacarbazin with Granulocyte-Colony-Stimulating Factor in HIV-infected patients with newly diagnosed Hodgkin Disease: a prospective, multi-institutional AIDS clinical trials group study (ACTG 149), JAIDS 2000; 24:444-450.
Navarro JT, Ribera JM, Grau J et al. Hodgkin disease in patients infected by human immunodeficiency virus. Study of fifteen cases, Med clin (Barc) 2000; 114 (1); 19-21.
Little RF, Yarchoan R, Wilson WH. Systemic chemotherapy for HIV-associated lymphoma in the era of highly active antiretroviral therapy, Curr Opin Oncol 2000; 12 (5); 438-444.
Errante D, Gabarre G, Ridolfo AL et al. Hodgkin disease in 35 patients with HIV infection: na experience with epirubicin, bleomicin, vimblastin and prednisone chemotherapy in combination with antiretroviral therapy and primary use of G-CSF, Ann Oncol 1999; 10(2):189-195.
Dennis A. Casciato, Barry B. Lowitz, Manual of clinical oncology, 2000 Lippincott Williams and Wilkins fourth edition 2000; 402; 682-685.
Tirelli U, Spina M, Gaidano G, Vaccher E, Franceschi S, Carbone A. Epidemiologiocal, biological and clinical features of HIV-related lynphomas in the era of high active antiretroviral therapy, AIDS 2000;14:1675-1688.
Hasenclever D, Diehl V, Armitage JO et al. A prognostic score for advanced Hodgkin’se Disease, NEJM 1998 ; 339:1506-1514.
Valerie L, Michael S. McGraath, Pathogenesis of HIV- Associated Lymphoma, HIV inSite Knowledge Base Chapter Published November 2002.
Hoffmann C, Chow KU, Wolf E et all. Outcome of HIV-associated Hodgkin disease is improved by highly active antiretroviral therapy. 7th International Conference on Malignancies and AIDS and Other Immunodeficiencies, April 28-29 Natcher Conference Center, Bethesda- Maryland, abs
Ficheiros Adicionais
Publicado
Como Citar
Edição
Secção
Licença
Este trabalho encontra-se publicado com a Licença Internacional Creative Commons Atribuição 4.0.
Direitos de Autor (c) 2023 Medicina Interna
Acesso livre
